Tivic Health Systems, Inc. TIVC

Full chart Compare
Set alert

Price alert · TIVC

All alert types
0.26 USD 0.00 (+0.00%)

Jul 29, 2026, 3:59 PM EDT

0.2531 Day range 0.2842

52-week range unavailable

YTD
-82.23%
1 year
-93.22%
Market cap
279.15K
Revenue (ttm)
1.11M
Shares out
8.27M
Forward P/E
-0.01
YTD return
-82.23%
1-year return
-93.22%
Volume
130.89K
Open
0.2842
Previous close
0.2577
Day's range
0.2531 – 0.2842
Beta
2.41
Earnings date
Mar 25, 2024

2Y -16.84 (-94.34%)

01020Jul 24Dec 24Apr 25Sep 25Feb 261.01

Key statistics

Enterprise value
-1.90M
PEG ratio
0.00
Price / sales
1.67
Price / book
0.09
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-13.00%
Free cash flow
-3.81M
Total cash
3.69M
Total debt
0
Return on equity
-183.60%
Short % of float
1.81%
50-day average
0.27238
200-day average
0.52189

Next earnings

Mar 25, 2024

Expected Mar 25, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
TIVC Revenue — quarterly -302.00K
2022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 2025
TIVC Net income — quarterly -2.85M
2022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 2025
TIVC EPS — quarterly -1.35
2022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 2025

Earnings

TIVC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.23——
Aug 14, 2024Jun 1, 20240.00-0.32——
May 15, 2024Mar 1, 20240.00-1.01——
Mar 25, 2024Dec 1, 20230.00———
Nov 14, 2023Sep 1, 2023-7.00-1.48+5.52+78.86%
Aug 14, 2023Jun 1, 2023-8.00-7.00+1.00+12.50%

About Tivic Health Systems, Inc.

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on TIVC — it syncs with the Stock Master app.

Insider holders

TIVC insider holders
InsiderRelationLatest transactionDateShares held
BAMBACH KIMBERLY ANNChief Financial OfficerStock Award(Grant)Mar 11, 20247,500

Institution ownership

TIVC institution ownership
Holder% heldSharesValueReported
UBS Group AG1.14%94,29821.16KSep 29, 2024
Vanguard Group Inc0.58%47,98110.77KSep 29, 2024
Geode Capital Management, LLC0.44%36,4578.18KSep 29, 2024
Two Sigma Securities, LLC0.35%28,5226.40KSep 29, 2024
Virtu Financial LLC0.25%20,9444.70KSep 29, 2024
Tower Research Capital LLC (TRC)0.22%18,3584.12KSep 29, 2024

Fund ownership

TIVC fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.58%47,98110.77KSep 29, 2024
Fidelity Extended Market Index Fund0.37%30,6686.88KOct 30, 2024
Fidelity Series Total Market Index Fund0.02%1,717385Oct 30, 2024